UCSF and Kaiser Permanente to Study Benefits and Harms of New and Older Blood-Thinning Drugs
UCSF and TPMG’s Division of Research received major funds for a study comparing the effectiveness of blood-thinning medications that prevent clots in the veins and lungs.
Heart Attacks Continue 15-Year Decline in Region
There was a 40 percent reduction in all types of heart attacks across Kaiser Permanente in Northern California from the peak in 2000 through 2014, the most recently studied year.
Ethnicity Influences Decisions About Prostate Cancer Treatment According to a New Study
A new study of more than 2,200 patients with low risk prostate cancer in an ethnically and economically diverse population revealed that ethnicity influences the decision to switch from observation only to active treatment.
Dementia’s Impact by Ethnicity to be Studied In California
Kaiser Permanente Northern California Division of Research will partner with the University of California, Davis, Alzheimer's Disease Center to undertake state-of-the-art brain imaging and cognitive testing of study participants, with funding from the National Institute on Aging.
Top Quality Cardiac Care for Complex Cases
In the U.S. News & World Report’s annual “Best Hospitals” 2016 report, Kaiser Permanente San Francisco Medical Center was, for the second year in a row, named among the Top 50 in the nation for the specialty of “cardiac care and heart surgery.”
TPMG Adopts Recommended Preventive Procedure for Ovarian Cancer
A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes.